(MENAFN- Baystreet.ca) 10:00 AM EST - Fennec Pharmaceuticals Inc. : Announced an amendment to its existing senior debt facility with the Life Sciences Group at Bridge Bank increasing the size of the facility from $12.5 million to $18 million. Fennec Pharmaceuticals Inc. shares T.FRX are trading unchanged at $12.68.
MENAFN2606202002120000ID1100391244
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.